CONTROL OF BLOOD-GLUCOSE LEVELS AND DEVELOPMENT OF DIABETIC MICRO-ANGIOPATHY - EFFECT OF GLIBORNURIDE

  • 1 January 1983
    • journal article
    • research article
    • Vol. 19  (4) , 311-318
Abstract
Genetically selected, sucrose-fed Cohen diabetic rats, aged 2 1/2 mo. were treated intragastrically with glibornuride, twice daily for 7 1/2 mo. The dose of 6-12.5 mg was adjusted according to the blood glucose level. Diabetic siblings with a similar metabolic derangement were used as a control group. Glibornuride treatment resulted in a significant reduction in blood glucose and an elevation in plasma insulin. A decreased incidence of diffuse glomerulosclerosis was noted in the treated group, in comparison with the control group (34.0 vs. 61.8%, P < 0.02). The incidence of retinal lesions was also lower in the glibornuride-treated group (16.7 vs. 48.0%, P < 0.02). Animals with diffuse glomerulosclerosis had significantly higher blood glucose and cholesterol levels and lower plasma insulin than did animals with normal kidneys.

This publication has 1 reference indexed in Scilit: